细胞生物学
线粒体
神经保护
线粒体融合
粒体自噬
线粒体内膜
生物
调解人
心磷脂
线粒体凋亡诱导通道
线粒体呼吸链
重编程
线粒体生物发生
线粒体膜转运蛋白
DNAJA3公司
脂质双层融合
膜电位
化学
缺血
微泡
细胞外
再灌注损伤
生物能学
呼吸链
再生(生物学)
线粒体通透性转换孔
作者
Ziheng Li,Xingjia Zhu,Weiquan Liao,Rui Jiang,Enze Sang,Jue Zhu,Gaojia Sun,Zhichao Lu,Chenxing Wang,Yi Jiang,Jian Chen,Peipei Gong,Qianqian null Liu
出处
期刊:Redox biology
[Elsevier BV]
日期:2026-03-02
卷期号:92: 104106-104106
被引量:4
标识
DOI:10.1016/j.redox.2026.104106
摘要
Mitochondrial dysfunction is a central driver of irreversible neuronal injury following ischemic stroke (IS); yet effective strategies to restore mitochondrial function and promote long-term neurological recovery remain limited. In this study, we demonstrate that mitochondrial extracellular vesicles derived from human umbilical cord mesenchymal stem cells (hUCMSC Mito-EVs) serve as a novel biotherapeutic vehicle capable of delivering functional mitochondria to damaged neurons. This process involves Target of Myb1-like 2 membrane trafficking protein (Tom1l2)-dependent membrane fusion between hUCMSC Mito-EVs and neuronal mitochondria, leading to the restoration of mitochondrial membrane potential and mitochondrial function. Mechanistically, Mito-EVs-mediated mitochondrial transfer upregulates cardiolipin synthase 1 (CRLS1), which preserves the inner mitochondrial membrane integrity and stabilizes respiratory chain complexes. The restoration of mitochondrial structure and function subsequently reduces reactive oxygen species production, suppresses pyroptosis, and promotes the recovery of neuronal metabolic and functional homeostasis. Collectively, these findings suggest that the Tom1l2-Crls1 axis serves as a key mediator of mitochondrial repair in hUCMSC Mito-EVs therapy, highlighting its promising potential as a targeted therapeutic strategy for neuronal protection following IS.
科研通智能强力驱动
Strongly Powered by AbleSci AI